Multiplexed DNA testing in minutes from a handheld device

SnapDNA is a startup based in Menlo Park, CA founded by top executives from semiconductor and biotech industries.  The company is funded by Silicon Valley pioneers and In-Q-Tel.  

What We Do

intel-silicon-hybrid-laser-

SnapDNA enables complex DNA tests in minutes from a fully automated low-cost handheld device. A DNA test is the most accurate way to diagnose a disease or uniquely identify a person or any living organism. DNA testing currently takes hours or days on expensive laboratory instruments. SnapDNA prototype sensors have successfully identified DNA markers in some of the most challenging DNA tests using biological test samples.

Have questions?  Contact us

News

Team

David Medin

CEO and Board Member

David Medin has 30 years experience in semiconductors, software and systems in consumer and commercial sectors.  He has founded and secured funding for multiple technology startups and has held CEO and CTO positions at private and public companies.  Prior companies include NVIDIA, TVIA, Spatial Photonics, Innovision, Tymphany, Maxcell Telecom.

Mr. Medin is an inventor on over 34 patents and applications with issued patents in 12 countries.  Mr. Medin has a B.S.E.E. from University of Maryland.

×
David Medin

David Medin

CEO and Board Member

S. Russ Lehrman Ph.D.

Dr. Lehrman, is VP of Chemistry and co-founder of SnapDNA.  He has more than 25 years experience leading analytical and formulation R&D in the biotechnology and pharmaceutical industries.  These programs improved the therapeutic value of proteins, small molecules, and nucleic acid-based clinical candidates at Elan, Nektar, NeXstar, and Pfizer (Upjohn).  He has also successfully developed novel formulations and analytical methodologies to support clinical development.  As an industry consultant, Dr. Lehrman has managed drug development operations for client companies, and has served as an expert witness in contract violation and patent infringement cases.

Dr. Lehrman has over 80 publications and 7 patents, is an Adjunct Professor at the University of Kansas, School of Pharmacy and is a frequent guest lecturer.  In addition, he has been an active organizer and contributor of mini symposia and group lecture series.  Dr. Lehrman received his B.Sc. in Chemistry from McGill University, Montreal, Canada, and Ph.D. in Pharmaceutical Chemistry from the University of Wisconsin-Madison.

×
S. Russ Lehrman Ph.D.

S. Russ Lehrman Ph.D.

Gabriel Matus

Mr. Matus has 15 years of experience working with high technology companies and early stage startups in technology development and pathfinding in MEMS, CMOS and silicon technologies. Prior to SnapDNA, Mr. Matus developed a process to make bulk materials based on silicon nanostructures, which can be used for megawatt scale energy harvesting from industrial waste heat at Alphabet Energy.  Prior to Alphabet, Mr. Matus developed micromirror and MEMS on CMOS fabrication and packaging technologies for Light Blue Optics, Spatial Photonics, MicroAssembly Technologies, Adriatic Research Institute and Onix Microsystems for diverse applications including fiber optic switching, freespace communication and high volume portable projection displays.  Mr. Matus has 6 issued patents, and 17 applications in progress.  Mr. Matus received his B.S. in Materials Science and Engineering from the University of California, Berkeley.

×
Gabriel Matus

Gabriel Matus

Veronica De Guzman Ph.D.

vdeguzman@snapdna.com

Veronica De Guzman has 13 years experience in formulation and pilot-scale manufacturing process development for biopharmaceutical companies such as Inhale (Nektar) Therapeutic Systems and MAP Pharmaceuticals (Allergan).  She also has over 10 years experience in single molecule DNA analysis.  Dr. De Guzman received her B.S. in Biological Sciences from University of California, Davis, and her Ph. D. in Biochemistry from University of California, Santa Cruz.

×
Veronica De Guzman Ph.D.

Veronica De Guzman Ph.D.

Les Vadasz

Board Member

Mr. Vadasz was Executive Vice President of Intel and President of Intel Capital until his retirement in 2003. He joined Intel in 1968 as part of the founding management team and lead the development of the company’s early products, including memory, EPROM and microprocessor components. Mr. Vadasz was a board member of Intel from 1988 to 2002, and Director Emeritus until 2004. He is a Fellow of the IEEE; served on a Presidential Commission as well as on a Board of the National Research Council.

×
Les Vadasz

Les Vadasz

Board Member

Regis McKenna

Board Member

Mr. McKenna is included in the San Jose Mercury News’ Millennium 100 as one of the 100 people who made Silicon Valley what it is today. Since 1970, Mr. McKenna has helped launch some of the most important technological innovations of the last thirty years including the first microprocessor (Intel Corporation), the first personal computer (Apple Computer), the first recombinant DNA genetically engineered product (Genentech, Inc.), and the first retail computer store (The Byte Shop). In the last decade, McKenna consulted on strategic marketing and business issues to industrial, consumer, transportation, healthcare, and financial firms in the United States, Japan, and Europe. McKenna continues to be involved in high tech start-up companies through his venture activities.

×
Regis McKenna

Regis McKenna

Board Member

Mark Breier

Board Observer

Mr. Breier is a Partner at IQT, a strategic investor for the U.S. Intelligence Community. Prior experiences include as CEO of Beyond.com, CMO of Plantronics, VP of Marketing for Amazon.com, as well as marketing executive positions at Kraft, Dreyer’s/Edy’s Ice Cream, and General Mills. Mark is also an author and public speaker, most recently of Life is A Game: Group Games for Kids, Teens, and Adults.

×
Mark Breier

Mark Breier

Board Observer

Contact

SnapDNA

1455 Adams Drive
Suite 1101
Menlo Park, CA 94025
(p) 650-265-6900
(f) 650-265-6906

Get directions

Send us a message

For more information, please contact us.